ervik.as
Back to CVE database

CVE-2026-90937

critical · CVSS 9.9Published 9/14/2026 at 01:19 PMCWE-93

froxlor versions before 2.2.5 fail to validate newline characters in subdomain redirect URLs, allowing authenticated customers to inject arb…

froxlor versions before 2.2.5 fail to validate newline characters in subdomain redirect URLs, allowing authenticated customers to inject arbitrary nginx or Apache configuration directives. Attackers can supply URLs containing literal newlines that are written verbatim into vhost config files during cron rebuild, enabling web server configuration corruption, denial of service, or hijacking of HTTP responses across hosted domains.

Why it matters

Internet-facing
Not identified as a common internet-facing category
Exploitation likelihood
high
  • Remotely exploitable over the network — no physical or local access required
  • Low attack complexity — no special conditions needed to exploit
  • Requires low-privilege access first
  • No user interaction needed — can be exploited automatically
Recommended mitigation

Apply the vendor patch as soon as it's available or already released. Review and restrict accounts with the privilege level this vulnerability requires.

This analysis is generated from structured CVSS vector data, CISA KEV cross-referencing, and vendor/product category rules — not a manual expert review. Treat it as a starting point, not a substitute for your own assessment.

CVSS Vector Breakdown

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:L
Attack Vector
Network
Complexity
Low
Privileges Req.
Low
User Interaction
None

EU Vulnerability Database (ENISA)

EUVD ID
EUVD-2026-77455
View on EUVD

EUVD is ENISA's EU vulnerability database, still in beta. EPSS is a probabilistic exploitation-likelihood score, not a certainty.

View official CVE record

Stay Updated

New CVEs and vulnerability advisories are added continuously as they're disclosed. Subscribe via RSS to get every update the moment it's published — no email or account required.

Subscribe via RSS
Share Share
Advertisement